Olumniant (barcitinab) from Eli Lilly gets EUA from US FDA for COVID-19 treatment EP News Bureau Nov 20, 2020 Baricitinib is an FDA-approved drug to treat rheumatoid arthritis
Scientists to investigate arthritis drug as potential therapy for vascular dementia EP News Bureau Oct 16, 2020 New funding by the British Heart Foundation awarded to the Universities of Sheffield and Manchester to investigate the link…
Actemra/RoActemra, arthritis drug from Roche fails to meet primary endpoint of COVID-19 trial EP News Bureau Jul 29, 2020 The COVACTA study did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe…
